Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Peritoneal Neoplasms × alvimopan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Constipation 2 Peritoneal Neoplasms 1 Opioid-Induced Constipation 1 Intestinal Diseases 1 Ileus 1

Interventions

Paclitaxel 10 Hyperthermic Intraperitoneal Chemotherapy 9 Cisplatin 9 Cytoreduction Surgical Procedures 8 Oxaliplatin 6 Mitomycin 5 Fluorouracil 4 Carboplatin 4 Bevacizumab 4 catumaxomab 3 sodium thiosulfate 2 Leucovorin 2 Drug Therapy 2 Doxorubicin 2 Docetaxel 2 Cetuximab 2 volociximab 1 vandetanib 1 relacorilant 1 pasireotide 1 nilotinib 1 farletuzumab 1 enzastaurin 1 birinapant 1 alvimopan 1 Surgical Procedures, Operative 1 Saline Waters 1 Platinum 1 Octreotide 1 Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03352414 2021-08-18

ILEUS

University of California, San Diego

Phase 2 Terminated

84 enrolled 10 charts

Peritoneal Neoplasms, Ileus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡